Have a personal or library account? Click to login
An Investigation of the Relationship Between the Enos Gene Polymorphism and Diagnosed Migraine Cover

An Investigation of the Relationship Between the Enos Gene Polymorphism and Diagnosed Migraine

Balkan Journal of Medical Genetics
Volume 17 (2014): Issue 2 (December 2014)
By: S. Güler,  H. Gürkan,  H. Tozkir,  N. Turan and  Y. Çelik  
Open Access
|Apr 2015

References

  1. 1. Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti S, et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache. 2006; 46(10): 1575-1579.10.1111/j.1526-4610.2006.00614.x17115991
    Search in Google Scholar
  2. 2. Toriello M, Oterino A, Pascual J, Castillo J, Colás R, Alonso-Arranz A, et al. Lack of association of endothelial nitricoxide synthase polymorphisms and migraine. Headache. 2008; 48(7): 1115-1119.10.1111/j.1526-4610.2008.01181.x18687083
    Search in Google Scholar
  3. 3. Gruber HJ, Bernecker C, Lechner A, Weiss S, Wallner-Blazek m, Meinitzer A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia. 2010; 30(4): 486-492.10.1111/j.1468-2982.2009.01964.x19673897
    Search in Google Scholar
  4. 4. Gkaliagkousi E, Douma S, Zamboulis C, Ferro A. Nitric oxide dysfunction in vascular endothelium and platelets: Role in essential hypertension. J Hypertens. 2009; 27(12): 2310-2320.10.1097/HJH.0b013e328330e89a19838132
    Search in Google Scholar
  5. 5. Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, et al. Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol. 2011; 30(6): 363-369.10.1089/dna.2010.115221332392
    Search in Google Scholar
  6. 6. Headache Classification Committee, International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia. 2004; 24(1): 1-160.
    Search in Google Scholar
  7. 7. Stovner, L, Hagen, K, Jensen, R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3): 193-210.10.1111/j.1468-2982.2007.01288.x17381554
    Search in Google Scholar
  8. 8. Gonçalves FM, Luizon MR, Speciali JG, Martins- Oliveira A, Dach F, Tanus-Santos JE, et al. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem. 2012; 370(1-2): 183-189.10.1007/s11010-012-1409-522865486
    Search in Google Scholar
  9. 9. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008; 120(2): 157-171.10.1016/j.pharmthera.2008.08.00318789357
    Search in Google Scholar
  10. 10. Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010 7(2): 183-190.10.1016/j.nurt.2010.03.006508409920430317
    Search in Google Scholar
  11. 11. Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, et al. NF-κB Activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia. 2006; 26(9): 1071-1079.10.1111/j.1468-2982.2006.01164.x16919057
    Search in Google Scholar
  12. 12. de O S Mansur T, Gonçalves FM, Martins- Oliveira A, Speciali JG, Dach F, Lacchini R, et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012; 364(1-2): 303-308.10.1007/s11010-012-1231-0
    Search in Google Scholar
  13. 13. Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Griffiths LR. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet. 2001; 105(1): 110-113.10.1002/1096-8628(20010108)105:1<;110::AID-AJMG1073>3.0.CO;2-#
    Search in Google Scholar
  14. 14. Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y. Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population. DNA Cell Biol. 2011; 30(2): 117-122.10.1089/dna.2010.1102
    Search in Google Scholar
  15. 15. Noseda R, Kainz V, Jakubowski M, Gooley JJ, Saper CB, Digre K, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010; 13(2): 239-245.10.1038/nn.2475
    Search in Google Scholar
  16. 16. Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology. 2001; 57(10): 1805-1811.10.1212/WNL.57.10.1805
    Search in Google Scholar
  17. 17. Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010; 7(2): 183-190.10.1016/j.nurt.2010.03.006
    Search in Google Scholar
  18. 18. Napoli R, Guardasole V, Zarra E, Matarazzo M, D’Anna C, Saccà F, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology. 2009; 72(24): 2111-2114.10.1212/WNL.0b013e3181aa53ce
    Search in Google Scholar
  19. 19. Myers DE. Potential neurogenic and vascular roles of nitric oxide in migraine headache and aura. Headache. 1999; 39(2): 118-124.10.1046/j.1526-4610.1999.3902118.x
    Search in Google Scholar
  20. 20. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001; 1(8): 719-725.10.1097/00008571-200111000-00011
    Search in Google Scholar
  21. 21. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med. 2005; 56(1): 303-320.10.1146/annurev.med.56.082103.104540
    Search in Google Scholar
  22. 22. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics. 2005; 15(8): 565-570.10.1097/01.fpc.0000167328.85163.44
    Search in Google Scholar
  23. 23. Wang J, Dudley D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency: Modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002; 22(5): e1-e4.10.1161/01.ATV.0000016248.51577.1F
    Search in Google Scholar
  24. 24. Lauer T, Kleinbongard P, Kelm M. Indexes of NO bioavailability in human blood. News Physiol Sci. 2002; 17(6): 251-255.10.1152/nips.01405.2002
    Search in Google Scholar
  25. 25. Metzger IF, Sertorio JTC, Tanus-Santos JE. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol. 2006; 188(2): 123-127.10.1111/j.1748-1716.2006.01612.x
    Search in Google Scholar
  26. 26. Metzger IF, Sertório JT, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med. 2007; 43(6): 987-992.10.1016/j.freeradbiomed.2007.06.012
    Search in Google Scholar
  27. 27. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE. Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Phar-macogenomics J. 2011; 11(6): 393-399.10.1038/tpj.2010.52
    Search in Google Scholar
  28. 28. Metzger IF, Luizon MR, Lacchini R, Ishizawa MH, Tanus-Santos JE. Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in Black subjects. Nitric Oxide. 2013; 28(1): 33-38.10.1016/j.niox.2012.10.002
    Search in Google Scholar
  29. 29. Sipahi T, Guldiken B, Kabayel L, Palabıyık O, Oskan H, Kılıç TO, et al. Endothelial nitric oxide synthase and angiotensin converting enzyme gene polymorphisms in migraine patients. Arch Neuropsychiatr. 2013; 50(1): 274-278.
    Search in Google Scholar
  30. 30. Guldiken B, Sipahi T, Guldiken S, Ustundag S, Budak M, Turgut N, et al. Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke. Mol Biol Rep. 2009; 36(6): 1539-1543.10.1007/s11033-008-9348-7
    Search in Google Scholar
  31. 31. Martelletti P, Lulli P, Morellini M, Mariani B, Pennesi G, Cappellacci S, et al. Chromosome 6pencoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol. 1999; 60(1): 69-74.10.1016/S0198-8859(98)00087-1
    Search in Google Scholar
  32. 32. Rainero I, Grimaldi LM, Salani G, Valfrè W, Rivoiro C, Savi L, et al. Association between the tumor necrosis factor-α -308 G/A gene polymorphism and migraine. Neurology. 2004; 62(1): 141-143.10.1212/01.WNL.0000101717.16799.8F14718719
    Search in Google Scholar
  33. 33. Rubino E, Fenoglio P, Gallone S, Govone F, Vacca A, De Martino P, et al. Genetic variants in the NOTCH4 gene influence the clinical features of migraine. J Headache Pain. 2013; 14(1): 28-32. 10.1186/1129-2377-14-28362043823566281
    Search in Google Scholar
DOI: https://doi.org/10.2478/bjmg-2014-0074 | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 49 - 59
Published on: Apr 10, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Migraine,
Aura,
Clinical features,
Endothelial nitric oxide synthase (eNOS) gene,
Polymorphisms
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2015 S. Güler, H. Gürkan, H. Tozkir, N. Turan, Y. Çelik, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 17 (2014): Issue 2 (December 2014)Next article